2023
CRP Versus SAA for Identification of Inflammatory Hepatic Adenomas
Soon G, Yasir S, Jain D, Kakar S, Wu T, Yeh M, Torbenson M, Chen Z. CRP Versus SAA for Identification of Inflammatory Hepatic Adenomas. Applied Immunohistochemistry & Molecular Morphology 2023, 31: 590-595. PMID: 37698958, DOI: 10.1097/pai.0000000000001155.Peer-Reviewed Original ResearchConceptsC-reactive proteinFocal nodular hyperplasiaHepatic adenomaInflammatory hepatic adenomaInflammatory adenomasNodular hyperplasiaH-scorePositive C-reactive proteinBeta-catenin activationProportion of casesInflammatory hepatocellular adenomaGlutamine synthetase stainingComplication riskRetrospective studyResection specimensPatient managementHepatocellular adenomaImmunohistochemical stainingSerum amyloidPositive stainingControl groupAdenomasIntense stainingMolecular classificationCRP staining
2011
Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance
Walther Z, Jain D. Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance. Pathology Research International 2011, 2011: 403929. PMID: 21559202, PMCID: PMC3090128, DOI: 10.4061/2011/403929.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsFocal nodular hyperplasiaHepatocellular carcinomaHepatocellular adenomaHepatic neoplasmsLiver cancerDysplastic nodulesMolecular classificationPrimary hepatic tumorsEarly hepatocellular carcinomaNovel therapeutic targetProgenitor cell phenotypeCommon malignancyPrognostic implicationsHCC-CCHepatic tumorsNodular hyperplasiaClinical significanceMolecular subtypesTherapeutic targetClinical practiceHepatic neoplasiaDistinct subtypesPatient careTumor phenotypeMolecular pathology